#argenx (ARGX)

Halozyme Therapeutics Q & A Yesterday, Halozyme Therapeutics ( HALO ) announced that Argenx Company ( ARGX ) has received United States FDA Administration approval of VYVGART® Hytrulo prefilled syring...

Halozyme and argenx Collaboration argenx (ARGX) dosed the first subject in phase 1 clinical trial for the safety, pharmacokinetics, and pharmacodynamics of its product efgartigimod plus Halozyme's (HA...

Halozyme Therapeutics (HALO)   and  argenx (ARGX)  announced a global collaboration and license agreement offering argenx the right to use Halozyme's ENHANZE® drug delivery technology to develop multi...

Phase 2 clinical trial data of argenx’s (ARGX) product Efgartigimod (ARGX-113) in adult patients with primary immune thrombocytopenia (ITP)  showed a favorable safety and tolerability profile. The res...